1. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, K, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021; 160(1): 99-114.e113.
2. Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, et al. Irritable bowel syndrome. Nature reviews. Disease primers. 2016; 2: 16014.
3. Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology. 2017; 152(1): 111-123.e118.
4. Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Alimentary pharmacology & therapeutics. 2015; 42(10): 1211-1221.
5. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2012; 24(6): 521-530, e248.
6. Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World journal of gastroenterology. 2014; 20(27): 8886-8897.
7. Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013; 62(1): 159-176.
8. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. The American journal of gastroenterology. 2006; 101(7): 1581-1590.
9. Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Alimentary pharmacology & therapeutics. 2005; 22(5): 387-394.
10. Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary pharmacology & therapeutics. 2008; 27(1): 48-57.
11. Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2012; 24(6): 513-520, e246-517.
12. Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. American journal of physiology. Gastrointestinal and liver physiology. 2016; 310(6): G417-426.
13. Li G, Yang M, Jin Y, Li Y, Qian W, Xiong H, Song J, Hou X. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome. Journal of gastroenterology and hepatology. 2018; 33(6): 1220-1226.
14. Zhong W, Lu X, Shi H, Zhao G, Song Y, Wang Y, Zhang J, Jin Y, Wang S. Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis. Journal of clinical gastroenterology. 2019; 53(9): 660-672.
15. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science (New York, N.Y.). 2005; 308(5728): 1635-1638.
16. Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology. 2019; 157(1): 97-108.
17. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015; 161(2): 264-276.
18. Mao B, Li D, Ai C, Zhao J, Zhang H, Chen W. Lactulose Differently Modulates the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice. Journal of agricultural and food chemistry. 2016; 64(31): 6240-6247.
19. Mandić AD, Woting A, Jaenicke T, Sander A, Sabrowski W, Rolle-Kampcyk U, von Bergen M, Blaut M. Clostridium ramosum regulates enterochromaffin cell development and serotonin release. Scientific reports. 2019; 9(1): 1177.
20. Miao L, Gong Y, Li H, Xie C, Xu Q, Dong X, Elwan HAM, Zou X. Alterations in cecal microbiota and intestinal barrier function of laying hens fed on fluoride supplemented diets. Ecotoxicology and environmental safety. 2020; 193: 110372.
21. Marteau P, Pochart P, Doré J, Béra-Maillet C, Bernalier A, Corthier G. Comparative study of bacterial groups within the human cecal and fecal microbiota. Applied and environmental microbiology. 2001; 67(10): 4939-4942.
22. Booijink CC, El-Aidy S, Rajilić-Stojanović M, Heilig HG, Troost FJ, Smidt H, Kleerebezem M, De Vos WM, Zoetendal EG. High temporal and inter-individual variation detected in the human ileal microbiota. Environmental microbiology. 2010; 12(12): 3213-3227.
23. M. Hamilton. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1): 50-55.
24. HAMILTON M. A rating scale for depression. Journal of neurology, neurosurgery, and psychiatry. 1960; 23: 56-62.
25. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary pharmacology & therapeutics. 1997; 11(2): 395-402.
26. Shen B, Liu W, Remzi FH, Shao Z, Lu H, DeLaMotte C, Hammel J, Queener E, Bambrick ML, Fazio VW. Enterochromaffin cell hyperplasia in irritable pouch syndrome. The American journal of gastroenterology. 2008; 103(9): 2293-2300.
27. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003; 125(6): 1651-1659.
28. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2005; 3(4): 349-357.
29. Y Li, H Xu, D Hua, B Zhao, H Mu, F Jin, G Meng, X Fang. Two-phase anaerobic digestion of lignocellulosic hydrolysate: Focusing on the acidification with different inoculum to substrate ratios and inoculum sources. The Science of the total environment. 2020; 699: 134226.
30. Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nature reviews. Gastroenterology & hepatology. 2013; 10(8): 473-486.
31. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6): 804-811.
32. Qin HY, Xavier Wong HL, Zang KH, Li X, Bian ZX. Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues. Life sciences. 2019; 239: 116886.
33. R Pittayanon, JT Lau, Y Yuan, GI Leontiadis, F Tse, M Surette, P Moayyedi. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology. 2019; 157(1): 97-108.
34. Sudo N. [Effects of Gut Microbiota on Stress Response and Behavioral Phenotype of the Host]. Brain and nerve = Shinkei kenkyu no shinpo. 2016; 68(6): 595-605.
35. Guo Y, Xie JP, Deng K, Li X, Yuan Y, Xuan Q, Xie J, He XM, Wang Q, Li JJ, et al. Bifidobacterium adolescentisProphylactic Effects of on Anxiety and Depression-Like Phenotypes After Chronic Stress: A Role of the Gut Microbiota-Inflammation Axis. Frontiers in behavioral neuroscience. 2019; 13: 126.
36. Li N, Wang Q, Wang Y, Sun A, Lin Y, Jin Y, Li X. Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress (Amsterdam, Netherlands). 2019; 22(5): 592-602.
37. Lyra A, Krogius-Kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, Korpela R, Palva A. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC gastroenterology. 2010; 10: 110.
38. E Malinen, L Krogius-Kurikka, A Lyra, J Nikkilä, A Jääskeläinen, T Rinttilä, T Vilpponen-Salmela, AJ von Wright, A Palva. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World journal of gastroenterology. 2010; 16(36): 4532-4540.
39. Allen-Vercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunology letters. 2014; 162: 54-61.
40. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, Lynch T, Allen-Vercoe E. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflammatory bowel diseases. 2011; 17(9): 1971-1978.
41. Zamani I, Bouzari M, Emtiazi G, Ghasemi SM, Chang HI. Molecular investigation of two novel bacteriophages of a facultative methylotroph, Raoultella ornithinolytica: first report of Raoultella phages. Archives of virology. 2019; 164(8): 2015-2022.